Resectable Pancreatic Ductal Adenocarcinoma (PDAC) Recruiting Phase 2 Trials for FAPi-46 GA-68 (DB18827)
Also known as: Resectable Pancreatic Ductal Adenocarcinoma
| Indication | Status | Phase |
|---|---|---|
| DBCOND0115304 (Resectable Pancreatic Ductal Adenocarcinoma (PDAC)) | Recruiting | 2 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT05518903 | An Investigational Scan (68Ga-FAPI-46 PET/CT) for the Imaging of Cancer-Associated Fibroblasts in Patients With Localized Pancreatic Ductal Adenocarcinoma | Diagnostic |